Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-12-009975
Filing Date
2012-06-11
Accepted
2012-06-11 17:29:34
Documents
4
Period of Report
2012-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 5928
2 ALDRICH POA aldrich_061112poa.txt EX-24.TXT 3965
3 DIPP POA dipp_061112poa.txt EX-24.TXT 3955
4 WESTPHAL POA westphal_061112poa.txt EX-24.TXT 3979
  Complete submission text file 0001179110-12-009975.txt   19448
Mailing Address 800 BOYLSTON SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON SUITE 1555 BOSTON MA 02199 (617) 351 2590
Longwood Fund, L.P. (Reporting) CIK: 0001483889 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-54647 | Film No.: 12901438

Mailing Address 800 BOYLSTON STREET, SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON STREET, SUITE 1555 BOSTON MA 02199 617-351-2590
OvaScience, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances